Summary of Purpose
Atrial fibrillation (AF) is the most preventable cause of stroke. However, despite widely available risk stratification tools, five options for oral anticoagulation, and evidence-based practice guidelines, anticoagulation for stroke prevention in AF is consistently under-prescribed. Data from our center (Brigham and Women's Hospital [BWH]) (1) demonstrate that fewer than 50% of outpatients with AF at high-risk...Read More →
The following dates are available for this trial. Trial information last updated on 5 November 2016.
|1 Jan 2017||5 Nov 2016||1 Dec 2019||Unavailable||1 Nov 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Gregory Piazza, MD, MS